Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

American Bio Medica To Release 2002 and Fourth Quarter Earnings and Host Conference Call.


Business Editors

KINDERHOOK, N.Y.--(BUSINESS WIRE)--Feb 5, 2003

American Bio Medica medica (māˑ·dē·k  Corporation (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: ABMC ABMC American Battle Monuments Commission
ABMC Alexian Brothers Medical Center (Illinois)
ABMC Aviation Battle Management Concept
ABMC Arrowbear Music Camp (California) 
), will release its 2002 and fourth quarter earnings on Thursday, February 6, 2003 after trading ends on the Nasdaq Stock Market Nasdaq stock market

The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies.
. The Company will also host a conference call on Friday, February 7, 2003, at 10:30 a.m. EST EST electroshock therapy.

EST
abbr.
electroshock therapy
 to discuss the 2002 and fourth quarter results and business outlook.

Investors and interested parties are invited to participate. The call will be broadcast live over the internet at www.abmc.com/investor/. The webcast will be listen-only mode. Listeners are requested to be online at least fifteen minutes early to register, as well as to download and install any complimentary audio software that might be required. To ask questions, you are invited to participate by phone. Within the United States, dial 1-800-915-4836 and internationally dial 973-317-5319. The call will be available for replay on the Company's website at www.abmc.com/investor/ for 30 days.

About American Bio Medica Corporation

American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate, onsite drugs-of-abuse diagnostic kits and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services  worldwide. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(R), Rapid One(R) and Rapid Tec(TM) test for the presence or absence of drugs of abuse in urine, while its OralStat6(R) tests for the presence or absence of drugs of abuse in saliva. ABMC was recently named among the 2002 Deloitte & Touche Technology Fast 500, a listing of the fastest-growing technology companies in North America.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 5, 2003
Words:263
Previous Article:PMA Capital Reports Fourth Quarter 2002 Results.
Next Article:Rush Enterprises Acquires Orange County Truck and Trailers Inc.
Topics:



Related Articles
American Bio Medica Announces Fourth Quarter and Fiscal Year 2002 Financial Results; Net Sales Increase 66% in Fourth Quarter and 63% From Prior Year.
American Bio Medica To Release First Quarter Earnings and Host Conference Call.
American Bio Medica Announces First Quarter Financial Results; Net Sales Increased 20% over Prior Year & 10% over Prior Quarter.
American Bio Medica Announces Third Quarter Results and Its Second Consecutive Record Quarter.
American Bio Medica Corporation Fourth Quarter and Year End 2003 Earnings Conference Call.
American Bio Medica Reports Second Consecutive Year of Growth in Sales and Earnings; Annual Sales Increase 21% and Net Income Increases 43%.
American Bio Medica Announces First Quarter Results.
American Bio Medica Reports Fiscal Year End 2004 Results.
American Bio Medica Reports Fiscal Year End 2005 Results.
American Bio Medica Reports Fourth Quarter and Fiscal Year End 2006 Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles